2012年是安捷伦中国承上启下,继往开来的一年。这一年,安捷伦完成有史以来规模最大的交易--收购丹麦癌症诊断公司Dako,同时这一年安捷伦完成了与瓦里安的业务整合。收购Dako与瓦里安之后,安捷伦在生命科学与化学分析领域地位得到进一步提升和拓展。在并购Dako之后,安捷伦在原有业务基础上新增诊断与基因业 2012 is a year that Agilent China has been undertaking, going forward. That year, Agilent completed the largest transaction ever - acquiring Dako, a Danish cancer diagnostics company, and Agilent completed its business integration with Varian this year. After the acquisition of Dako and Varian, Agilent’s position in life sciences and chemical analysis has been further enhanced and expanded. After acquiring Dako, Agilent added diagnostics and genetics to its existing operations